Background and objective Approximately 89% of patients with Parkinson’s disease (PD) suffer from dysarthria. beta-catenin inhibitor Lee Silverman Voice Treatment (LSVT), a behavioral therapy, aims at improving speech and voice functions. The objective was to assess the effectiveness of LSVT compared with other/no speech interventions for…[Read more]